Clin2
NCT07224490Possibly a fitRecruiting

Kisspeptin test for brain function after COVID-19

Reproductive DisorderNeurodegenerationSARS-CoV 2Long COVID

Treatments studied

Part of Infections, Lungs & breathing clinical trials.

This study tests how the brain's reproductive hormone system works after a COVID-19 infection using a substance called kisspeptin. It may help explain symptoms like changes in periods or hormone levels in people with long COVID.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
40 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • Women ages 18 to 45 or men ages 18 to 60
  • No current use of hormones or medications that affect the reproductive system (or you must be willing to stop them for a while first)
  • Women must have a negative pregnancy test before starting
  • For the long COVID group: you have been diagnosed with post-COVID-19 syndrome
  • For the control group: you had COVID-19 but did not develop long COVID
  • No active illegal drug use (marijuana is allowed)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06992401Not yet recruiting
Nasal IVIG study for long COVID patients with immune problems

This study tests whether a nasal spray form of IVIG (an immune-boosting treatment) can help people with Long COVID who also have certain immune system issues. It aims to see if the treatment is safe and effective for this group of patients.

NCT06920628Recruiting· Phase 1
Brain scan study for long COVID neurological symptoms

This study uses a special PET scan to look at brain inflammation in people with neurological symptoms after COVID-19. It aims to understand how inflammation might be linked to ongoing problems like brain fog or memory issues.

Bethesda, Maryland
NCT06883513Recruiting
Osteopathic therapy for long COVID symptoms

This trial tests if gentle hands-on treatment (osteopathic manipulative therapy) can help relieve long-lasting COVID symptoms like fatigue, brain fog, and body pain.

Louisville, Kentucky
NCT07224438Recruiting· Phase 2
Kisspeptin injections for menopause-like condition from stress or diet

This trial tests if kisspeptin injections can help women with hypothalamic amenorrhea (a pause in periods due to stress, low weight, or too much exercise). The goal is to see if it can restart the reproductive system naturally.

Boston, Massachusetts
NCT05896293Recruiting· Phase 2
Kisspeptin shots for low hormone condition

This study tests if a hormone called kisspeptin can help people with a condition that limits sex hormones. The trial involves regular shots under the skin.

Boston, Massachusetts
NCT02081924Recruiting
Testing kisspeptin hormone delivery and blood hormone changes

This study gives the hormone kisspeptin over time and measures how your body’s reproductive hormones respond. It may help researchers understand how reproductive hormone signals work, which could guide future treatments.

London

Hear when a new Neurodegeneration trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.